Difference between revisions of "Pilot Conformance Projects Under Development"
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
QIBA Profiles that are at least at consensus level (link to wiki page on development of a Profile) are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile. | QIBA Profiles that are at least at consensus level (link to wiki page on development of a Profile) are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile. | ||
There are two different ways to show QIBA Profile conformance: | There are two different ways to show QIBA Profile conformance: | ||
| − | *Self | + | *Self Attestation |
*Certification service | *Certification service | ||
| Line 20: | Line 20: | ||
===CT: Lung Tumor Volume (Advanced Disease)=== | ===CT: Lung Tumor Volume (Advanced Disease)=== | ||
| − | + | '''Profile''' | |
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]] | * [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]] | ||
| − | + | '''Checklist''' | |
| − | + | * [[Media: QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Checklist_20191111.pdf | CT Conformance Checklist]] (can also refer to Appendix C in the Profile document - pg 42) | |
| − | + | * Assessment Procedures (refer to Section 4 in the Profile document - pg 30) | |
| − | : | + | :*[[Media:QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Supplement_2019051111.pdf | CT Conformance Testing Supplement, 2019-11-11]] |
| − | + | '''Report Template''' | |
===FDG-PET: Solid Tumor SUV=== | ===FDG-PET: Solid Tumor SUV=== | ||
| − | + | '''Profile''' | |
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]] | * [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]] | ||
| − | + | '''Checklist''' | |
* [[Media:QIBA FDG PETCT _Conformance Testing_Checklist_20191111.pdf | QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11]] | * [[Media:QIBA FDG PETCT _Conformance Testing_Checklist_20191111.pdf | QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11]] | ||
| − | + | '''Report Template''' | |
| − | ===MR: ADC | + | ===DWI MR: ADC of Lesions in Four Organs=== |
| − | + | '''Profile''' | |
*[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]] | *[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]] | ||
| − | + | '''Checklist''' | |
*[[Media:QIBA DWI Profile _Conformance Testing_Checklist_20191111.pdf | QIBA DWI-MRI Conformance Checklist, 2019-11-11]] | *[[Media:QIBA DWI Profile _Conformance Testing_Checklist_20191111.pdf | QIBA DWI-MRI Conformance Checklist, 2019-11-11]] | ||
**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 1_20191111.pdf | QIBA DWI Conformance Testing Supplement #1, 2019-11-11]] | **[[Media:QIBA DWI Profile _Conformance Testing_Supplement 1_20191111.pdf | QIBA DWI Conformance Testing Supplement #1, 2019-11-11]] | ||
**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]] | **[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]] | ||
| − | + | '''Report Template''' | |
Revision as of 21:44, 18 November 2019
QIBA Profile Conformance
{This content will eventually be available on the RSNA.org website.}
QIBA Profiles that are at least at consensus level (link to wiki page on development of a Profile) are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile. There are two different ways to show QIBA Profile conformance:
- Self Attestation
- Certification service
The basic process flow is shown below:
Before starting conformance testing, please Email QIBA
Self Attestation of Conformance
The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.
CT: Lung Tumor Volume (Advanced Disease)
Profile
Checklist
- CT Conformance Checklist (can also refer to Appendix C in the Profile document - pg 42)
- Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
Report Template
FDG-PET: Solid Tumor SUV
Profile
Checklist
Report Template
DWI MR: ADC of Lesions in Four Organs
Profile
Checklist
Report Template